Foundayo
PERSON · 8 article mentions
Recent mentions
- Eli Lilly says its next gen obesity drug is more powerful than Zepbound and Wegovy
- Eli Lilly says next-generation weight loss drug clears crucial obesity trial
- Novo Nordisk’s next obesity battlefront: Winning beyond America
- The FDA approves a new obesity pill, giving patients another option
- A new Medicare option for weight loss drugs is coming: Here's what to know
- Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance
- Eli Lilly shares surge on a beat-and-raise, proving the stock's swoon was a mistake
- More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says